Clinical trial
Research Evaluating the Value of Augmenting Medication With Psychotherapy
NCT00057551 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00057551 |
|---|---|
| Title | Research Evaluating the Value of Augmenting Medication With Psychotherapy |
| Official title | CBASP Augmentation for Treatment of Chronic Depression |
| Acronym | REVAMP |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression, Depressive Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Brief Supportive Psychotherapy, CBASP, Medication Only |
| Enrollment | 491 |
| Start date | Apr 1, 2003 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Apr 7, 2003 |
| Last update posted | Dec 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: